Vincent O'Neill's Net Worth
$4.67 Million
Who is Vincent O'Neill?
Vincent O'Neill has an estimated net worth of $4.67 Million. This is based on reported shares across multiple companies, which include BioXcel Therapeutics, Inc., and Mirna Therapeutics, Inc..
SEC CIK
Vincent O'Neill's CIK is 0001672718
Past Insider Trading and Trends
2023 was Vincent O'Neill's most active year for acquiring shares with 7 total transactions. Vincent O'Neill's most active month to acquire stocks was the month of February. 2021 was Vincent O'Neill's most active year for disposing of shares, totalling 13 transactions. Vincent O'Neill's most active month to dispose stocks was the month of December. 2021 saw Vincent O'Neill paying a total of $126,400.00 for 60,000 shares, this is the most they've acquired in one year. In 2023 Vincent O'Neill cashed out on 63,918 shares for a total of $908,032.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BioXcel Therapeutics, Inc. (BTAI) Snapshot price: $0.511
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.87% | 383 |
$0.69 | -$95.33 | 3.91K |
Scheduled
|
Sep 14 - Sep 16
| ||
Form 4
| +11.59% | 366 |
$1.29 | -$199.17 | 3.52K |
Scheduled
|
Jun 14 - Jun 17
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +93.00% | 2.61K |
$2.62 | -$432.48 | 5.41K |
Scheduled
|
Mar 14 - Apr 4
| ||
Form 4
| +22.84% | 521 |
—
|
—
| 2.8K |
Dec 14
| |||
Form 4
| +29.60% | 521 |
—
|
—
| 2.28K |
Sep 14
| |||
Form 4
| +42.05% | 521 |
—
|
—
| 1.76K |
Jun 14
| |||
Form 4
|
∞
| 1.24K |
$19.70 | -$16,642.28 | 1.24K |
Scheduled
|
Mar 14 - Mar 15
| ||
Form 4
|
—
|
0
|
$15.21 | -$879,207.67 |
0
|
Scheduled
|
Jan 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
$30.12 | -$1,273,309.15 |
0
|
Scheduled
|
Feb 17
| ||
Form 4
|
—
|
0
|
$24.94 | -$1,226,469.14 |
0
|
Scheduled
|
Jan 19
| ||
Form 4
|
—
|
0
|
$25.93 | -$1,275,906.68 |
0
|
Scheduled
|
Dec 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirna Therapeutics, Inc. (SYBX) Snapshot price: $1.58
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||